Montes-Ramírez, M. L.Miró Meda, José MaríaQuereda, CarmenJou, A.Von Wichmann, Miguel A.Berenguer, JuanGonzález García, J. J.Hernando Jeréz, María AsunciónOrtega, EduardoSanz, J.Arribas, José R.2015-01-212015-01-212014Montes-Ramírez, M. L., Miró, J. M., Quereda, C., Jou, A., Wichmann, M. A., Berenguer, J., ..., & Arribas, J. R. (2014). Incidence of hepatocellular carcinoma in HIV-infected patients with cirrhosis: a prospective study. JAIDS: Journal of Acquired Immune Deficiency Syndromes, 65(1), 82-86.15254135http://hdl.handle.net/11268/3818This study assesses the incidence of hepatocellular carcinoma (HCC) in a prospective cohort of HIV-infected patients, the majority receiving antiretroviral therapy, with liver cirrhosis from different etiologies, enrolled between 2004 and 2005 with median follow-up of 5 years. We followed 371 patients, 25.6% with decompensated cirrhosis at baseline. The incidence rate of HCC was 6.72 per 1000 person-years [95% confidence interval (CI): 2.6 to 10.9]. There was a trend toward a higher cumulative probability of developing HCC at 6 years of follow-up (considering death and liver transplant as competing risks) in patients with decompensated versus compensated cirrhosis at baseline (6% vs. 2%, P , 0.06). Key Words: HIV, viral hepatitis, liver cirrhosis, hepatocellular carcinoma, incidenceengjournal article10.1097/QAI.0b013e3182a685dcrestricted accessCancerOncologíaCáncer